Immune landscape of breast tumors with low and intermediate estrogen receptor expression

Immune checkpoint blockade (ICB) is currently approved for patients with triple-negative breast cancer (TNBC), whereas responses to ICB are also observed in a small subgroup of Estrogen Receptor (ER)-positive breast cancer. The cut-off for ER-positivity (≥1%) is based on likelihood of endocrine trea...

Full description

Bibliographic Details

Published in:	NPJ breast cancer Vol. 9; no. 1; pp. 39 - 10
Main Authors:	Voorwerk, Leonie, Sanders, Joyce, Keusters, Milou S., Balduzzi, Sara, Cornelissen, Sten, Duijst, Maxime, Lips, Esther H., Sonke, Gabe S., Linn, Sabine C., Horlings, Hugo M., Kok, Marleen
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 13.05.2023 Nature Publishing Group Nature Portfolio
Subjects:	631/67 631/67/580 692/4028/67/1347 Biomedical and Life Sciences Biomedicine Breast cancer Cancer Research Cell Biology Estrogens Human Genetics Oncology Tumors
ISSN:	2374-4677, 2374-4677
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!